4 Results for "

CDK/HDAC-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CDK/HDAC-IN-1" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-132914
CAS No.: 2762181-73-5
Target:  

CDK

Research Areas:  

Cancer

CDK/HDAC-IN-1 shows remarkable CDK2/4/6 and HDAC6 inhibitory activity of IC50 = 60.9 ± 2.9, 276 ± 22.3, 27.2 ± 4.2, and 128.6 ± 0.4 nM, respectively.
loading...
    loading...
Cat. No.: HY-170651
Target:  

CDK HDAC Apoptosis

Research Areas:  

Cancer

CDK4/6/HDAC-IN-1 (Compound N14) is a dual-targeting inhibitor of CDK4/6 and HDAC (IC50: CDK4 = 7.23 nM, CDK6 = 13.20 nM, HDAC1 = 55.66 nM, HDAC6 = 48.38 nM). CDK4/6/HDAC-IN-1 induces cell Apoptosis and G0/G1 phase arrest through HDAC-p21-CDK signaling pathway. CDK4/6/HDAC-IN-1 inhibits hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-178350
Research Areas:  

Cancer

MFDCH016 is a potent HDAC1/6 (IC50 = 38/59 nM) and CDK4/6 (IC50 = 680/720 nM) inhibitor. MFDCH016 induces apoptosis and cell cycle arrest in G2/M and G0/G1 phases in MCF-7 cells. MFDCH016 can modulate the HDAC-p21-CDK signaling pathway, increasing the levels of acetylated H3 and p21. MFDCH016 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-143497
CAS No.: 2418559-01-8
Target:  

HDAC CDK Apoptosis

Research Areas:  

Cancer

HDAC1/2 and CDK2-IN-1 (compound 14d) is a potent HDAC1, HDAC2 and CDK2 dual inhibitor, with IC50 values of 70.7, 23.1 and 0.80 μM, respectively. HDAC1/2 and CDK2-IN-1 can block the cell cycle and induce apoptosis. HDAC1/2 and CDK2-IN-1 exhibits desirable in vivo antitumor activity .
loading...
    loading...